Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 8:00 PM View:  | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 23-Apr-24 | Purchase | 48,203 | $13.15 | $633,869.00 | 2% 2.74M to 2.79M | |
| 23-Apr-24 8:00 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 22-Apr-24 | Private Purchase | 2,022 | $12.88 | $26,043.40 | < 1% 2.74M to 2.74M | |
| 22-Apr-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 19-Apr-24 | Purchase | 42,459 | $12.84 | $545,174.00 | 2% 2.69M to 2.74M | |
| 22-Apr-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 18-Apr-24 | Private Purchase | 81,738 | $12.80 | $1,046,250.00 | 3% 2.61M to 2.69M | |
| 12-Apr-24 9:20 AM View: | Goetz Kathleen Director | H&Q Life Sciences Investors (HQL) | 09-Apr-24 | Private Purchase | 400 | $13.32 | $5,327.32 | 58% 0.69K to 1.08K | |
| 04-Jan-24 2:23 PM View: | Reit Todd Director | H&Q Life Sciences Investors (HQL) | 02-Jan-24 | Private Purchase | 1,000 | $13.80 | $13,798.00 | 100% 0 to 1.0K | |
| 02-Jan-24 4:34 PM View: | Maher Bill Director | H&Q Life Sciences Investors (HQL) | 28-Dec-23 | Private Purchase | 1,000 | $13.57 | $13,570.00 | 100% 0 to 1.0K | |
| 25-Sep-23 5:35 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 25-Sep-23 | Private Purchase | 10,096 | $12.39 | $125,116.00 | 5% 187.42K to 197.52K | |
| 20-Sep-23 6:40 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 20-Sep-23 | Private Purchase | 12,000 | $12.68 | $152,206.00 | 7% 175.42K to 187.42K | |
| 24-Mar-22 3:16 PM View: | Goetz Kathleen Director | H&Q Life Sciences Investors (HQL) | 23-Mar-22 | Private Purchase | 92 | $16.27 | $1,501.85 | 16% 0.59K to 0.69K | |
| 27-Jan-22 1:33 PM View: | Goetz Kathleen Director | H&Q Life Sciences Investors (HQL) | 26-Jan-22 | Market Purchase | 593 | $17.54 | $10,403.70 | 100% 0 to 0.59K | 6% |
| 12-Aug-21 11:40 AM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 11-Aug-21 | Market Purchase | 6,403 | $21.63 | $138,497.00 | 5% 140.09K to 146.49K | (< 1%) |
| 26-Oct-20 5:27 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 26-Oct-20 | Market Purchase | 6,175 | $17.52 | $108,204.00 | 5% 125.66K to 131.84K | 13% |
| 21-Oct-20 7:18 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 21-Oct-20 | Market Purchase | 5,950 | $17.75 | $105,606.00 | 5% 119.71K to 125.66K | 11% |
| 23-Sep-20 3:56 PM View: | Bailey Jeffrey Allen Director | H&Q Life Sciences Investors (HQL) | 22-Sep-20 | Market Purchase | 580 | $17.28 | $10,022.40 | 100% 0 to 0.58K | 15% |
| 22-May-20 11:05 AM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 21-May-20 | Market Purchase | 5,950 | $17.74 | $105,557.00 | 5% 108.87K to 114.82K | 7% |
| 17-Mar-20 6:25 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 17-Mar-20 | Market Purchase | 8,300 | $13.27 | $110,107.00 | 9% 97.51K to 105.81K | 43% |
| 29-Jan-18 10:07 AM View: | Kent Thomas M Director | H&Q Life Sciences Investors (HQL) | 25-Jan-18 | Market Purchase | 1,300 | $21.04 | $27,348.00 | 100% 0 to 1.3K | (19%) |
| 29-Jun-15 2:47 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 29-Jun-15 | Market Purchase | 1,000 | $28.17 | $28,170.00 | (14%) 6.99K to 5.99K | 44% |
| 01-Jul-14 5:13 PM View: | Reardon William S Director | H&Q Life Sciences Investors (HQL) | 30-Jun-14 | Market Purchase | 200 | $19.75 | $3,950.00 | 14% 1.41K to 1.61K | (14%) |
| 30-Jun-14 5:34 PM View: | Pohotsky Oleg M Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 76 | $19.75 | $1,501.00 | 33% 0.23K to 0.3K | (14%) |
| 01-Jul-14 5:13 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 14,688 | $19.75 | $290,088.00 | 33% 44.07K to 58.76K | (14%) |
| 30-Jun-14 5:35 PM View: | Reardon William S Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 578 | $19.75 | $11,415.50 | 69% 0.83K to 1.41K | (14%) |
| 11-Jul-14 2:27 PM View: | Reinhardt Uwe E Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 752 | $19.75 | $14,852.00 | 33% 2.26K to 3.01K | (14%) |
| 30-Jun-14 5:34 PM View: | Bonney Michael W Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 1,459 | $19.75 | $28,815.20 | 157% 0.93K to 2.39K | (14%) |
| 30-Jun-14 5:35 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 1,000 | $19.75 | $19,750.00 | 17% 5.99K to 6.99K | (14%) |
| 04-Jun-13 4:36 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 04-Jun-13 | Market Purchase | 6,000 | $17.58 | $105,473.00 | 17% 34.98K to 40.98K | 4% |
| 21-Mar-12 12:16 PM View: | Pohotsky Oleg M Director | H&Q Life Sciences Investors (HQL) | 19-Mar-12 | Market Purchase | 200 | $13.30 | $2,659.98 | 100% 0 to 0.2K | 51% |
| 12-Mar-12 1:20 PM View: | Reardon William S Director | H&Q Life Sciences Investors (HQL) | 09-Mar-12 | Market Purchase | 772 | $13.27 | $10,241.40 | 100% 0 to 0.77K | 51% |
| 12-Mar-12 5:12 PM View: | Bonney Michael W Director | H&Q Life Sciences Investors (HQL) | 09-Mar-12 | Market Purchase | 800 | $13.25 | $10,603.70 | 100% 0 to 0.8K | 51% |
| 08-Aug-11 5:11 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 08-Aug-11 | Market Purchase | 10,000 | $10.03 | $100,328.00 | 52% 19.36K to 29.36K | 114% |
| 06-Aug-09 11:53 AM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 06-Aug-09 | Market Purchase | 3,000 | $8.61 | $25,840.00 | 21% 14.62K to 17.62K | 177% |
| 19-May-09 9:34 AM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 18-May-09 | Market Purchase | 1,500 | $8.14 | $12,210.00 | 44% 3.45K to 4.95K | 194% |
| 01-Dec-08 2:24 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 26-Nov-08 | Market Purchase | 2,000 | $6.89 | $13,780.00 | 17% 11.52K to 13.52K | 249% |
| 14-Oct-08 4:35 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 10-Oct-08 | Market Purchase | 2,000 | $7.90 | $15,800.00 | 21% 9.52K to 11.52K | 147% |
| 27-Feb-08 12:51 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 25-Feb-08 | Market Purchase | 1,800 | $12.65 | $22,770.00 | 142% 1.27K to 3.07K | 54% |
| 02-Jan-08 2:24 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 31-Dec-07 | Market Sale | 2,000 | $13.12 | $26,240.00 | (63%) 3.19K to 1.19K | (52%) |
| 26-Nov-07 12:23 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 21-Nov-07 | Market Purchase | 1,500 | $12.50 | $18,750.00 | 21% 7.17K to 8.67K | 60% |
| 06-Aug-07 2:11 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 03-Aug-07 | Market Purchase | 1,000 | $13.20 | $13,200.00 | 17% 6.02K to 7.02K | 59% |
| 12-Feb-07 1:33 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 09-Feb-07 | Market Purchase | 3,000 | $14.98 | $44,930.10 | 100% 0 to 3.0K | 45% |
| 02-Oct-06 12:40 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 28-Sep-06 | Market Purchase | 1,666 | $12.82 | $21,358.10 | 42% 4.0K to 5.67K | 73% |
| 22-Mar-07 3:27 PM View: | Lewin Lawrence S Director | H&Q Life Sciences Investors (HQL) | 20-Sep-06 | Market Purchase | 973 | $12.82 | $12,473.90 | 50% 1.95K to 2.92K | 73% |
| 05-Apr-05 11:54 AM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 01-Apr-05 | Market Purchase | 2,900 | $14.50 | $42,050.00 | 272% 1.06K to 3.96K | 81% |
| 02-Aug-04 3:39 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 29-Jul-04 | Market Purchase | 400 | $14.38 | $5,752.00 | 65% 0.62K to 1.02K | 94% |
